Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000950117-12-000600
Filing Date
2012-03-28
Accepted
2012-03-28 16:24:03
Documents
1
Period of Report
2012-03-14

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 4 cfp_20664.html 4/A  
1 AMENDMENT TO FORM 4 cfp_20664.xml 4/A 10370
  Complete submission text file 0000950117-12-000600.txt   11916
Mailing Address C/O IBIOPHARMA, INC. 9 INNOVATION WAY SUITE 100 NEWARK DE 19711
Business Address
MCKEY JOHN D JR (Reporting) CIK: 0001120452 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35023 | Film No.: 12720888

Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations